Tech Company Financing Transactions

iZumi Bio Funding Round

Highland Capital Partners and Kleiner Perkins Caufield & Byers participated in a $20 million capital raise for iZumi Bio. The round was announced on 4/14/2009.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

951 Gateway Blvd
South San Francisco, CA 94080
USA

Phone

650-872-4700

Website

www.izumibio.com

Email Address

[email protected]

Overview

iZumi Bio is a biotechnology company focused on broad, paradigm-changing applications of cellular reprogramming and directed differentiation of human cells made possible by the scientific breakthrough of induced pluripotent stem (iPS) cell technology. The name iZumi is Japanese for fountain of youth.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

John Walker

        

Browse more venture capital transactions:

Prev: 4/14/2009: FastSoft venture capital transaction
Next: 4/14/2009: Goom Radio venture capital transaction

Share this article

About Our VC Transactions Data

Our team works diligently to document tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary